RxDoctor Payments Data

Shannon Roberts, DO

Internal Medicine · Lexington, KYNPI 1447279047

Payments from drug & device makers

$9,053in general payments, 2019–2025

Across 585 payments — averaging $15.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Lilly USA, LLC$891
  • Pfizer$838
  • Boehringer Ingelheim$747
  • Amgen$724
  • Novo Nordisk$564
  • plus $4K from 50 others

What the payments were for

  • Food & beverage$9,053100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)98$1,347
Lilly USA, LLC52$891
Pfizer60$838
Boehringer Ingelheim58$747
Amgen47$724
Novo Nordisk41$564
GSK31$478
Astellas Pharma US Inc17$318
Sanofi-aventis U.S. LLC18$254
Sumitomo Pharma America, Inc.10$196
Bayer12$195
Novartis10$181
Vanda Pharmaceuticals Inc.6$161
Axsome Therapeutics, Inc.5$142
Johnson & Johnson8$139
Merck9$132
Abbott6$114
Dynavax Technologies Corporation6$108
Xeris Pharmaceuticals, Inc.5$107
Biohaven Pharmaceutical Holding Company Ltd.6$91
Upsher-smith Laboratories LLC5$89
AstraZeneca6$85
Neurocrine Biosciences, Inc.3$79
Corcept Therapeutics5$74
Esperion Therapeutics, Inc.5$67
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC4$62
Amarin Pharma, Inc.4$58
Idorsia Pharmaceuticals US Inc3$56
Sunovion Pharmaceuticals Inc.3$55
Takeda Pharmaceuticals U.S.A., Inc.3$50
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)3$50
Shire North American Group Inc3$45
Gilead2$42
Teva Pharmaceuticals USA, Inc.3$42
Verona Pharma, Inc.2$41
Kowa Pharmaceuticals America, Inc.3$41
Otsuka America Pharmaceutical, Inc.2$40
Phathom Pharmaceuticals, Inc.2$34
Amneal Pharmaceuticals LLC2$32
Nevro Corp.1$30
Eisai Inc.1$24
Almatica Pharma LLC1$23
Alnylam Pharmaceuticals Inc.1$20
Phadia US Inc.1$19
Sage Therapeutics, LLC1$17
Acadia Pharmaceuticals Inc1$17
E.r. Squibb & Sons, L.L.C.1$15
Tandem Diabetes Care, Inc.1$14
Inspire Medical Systems, Inc.1$14
Boston Scientific1$14
Medline Industries LP1$14
Radius Health, Inc.1$14
Biogen1$13
Biohaven Pharmaceuticals, Inc.1$12
Regeneron Healthcare Solutions, Inc.1$12
Daiichi Sankyo Inc.1$11

How this compares

$9,053 in reported general payments places this provider in the 90th percentile of 1,284 internal medicine providers in Kentucky.

See all internal medicine providers in Kentucky

Medicare billing

Part B allowed, 2024
$119,302
Medicare patients
239
Services billed
1,535

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide63$67,922
EliquisApixaban76$60,780
JanuviaSitagliptin Phosphate53$46,417
JardianceEmpagliflozin14$17,708
Trelegy ElliptaFluticasone/Umeclidin/Vilanter14$12,499
Repatha SureclickEvolocumab11$7,205
Fluticasone-SalmeterolFluticasone Propion/Salmeterol14$5,190
PremarinEstrogens, Conjugated14$4,362
Levothyroxine Sodium425$4,054
Lantus SolostarInsulin Glargine,hum.Rec.Anlog33$3,187
SynthroidLevothyroxine Sodium76$2,504
Bupropion XlBupropion Hcl106$2,078
Atorvastatin Calcium353$2,051
Rosuvastatin Calcium157$1,857
Pravastatin Sodium178$1,748

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$564$67,92263 claims
PfizerEliquis, Premarin$838$65,14290 claims
MerckJanuvia$132$46,41753 claims
Boehringer IngelheimJardiance$747$17,70814 claims
GSKTrelegy Ellipta$478$12,49914 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$32$4,054425 claims
AbbVieSynthroid$1,347$2,50476 claims
Almatica Pharma LLCSertraline Hcl$23$668126 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,284 internal medicine providers in Kentucky.

Other internal medicine in Lexington

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →